DiaMedica Therapeutics Inc.
DMAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $219,397 | $92,487 | $41,780 | $77,485 |
| - Cash | $3,025 | $4,543 | $4,728 | $4,707 |
| + Debt | $340 | $400 | $469 | $52 |
| Enterprise Value | $216,712 | $88,344 | $37,521 | $72,830 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$26,642 | -$21,237 | -$13,976 | -$13,622 |
| % Margin | – | – | – | – |
| Net Income | -$24,444 | -$19,381 | -$13,676 | -$13,592 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.6 | -0.6 | -0.52 | -0.65 |
| % Growth | 0% | -15.4% | 20% | – |
| Operating Cash Flow | -$22,076 | -$18,728 | -$11,511 | -$12,252 |
| Capital Expenditures | -$25 | -$24 | -$81 | -$22 |
| Free Cash Flow | -$22,101 | -$18,752 | -$11,592 | -$12,274 |